Comments
Loading...

Corvus Pharma Informe de interés a corto plazo

CRVSNASDAQ
Logotipo presentado por Benzinga Data
$5.74
-0.14-2.38%
al cierre: -
$5.74
0.000.00%
After hour: 4:00 PM EDT

Informe de interés en corto

El interés corto en Corvus Pharmaceuticals Inc (NASDAQ:CRVS) ha aumentado durante el último período de informe, aumentando en aumento desde 9.29M hasta 9.59M. Esto representa el 16.29% de las acciones disponibles públicamente de la empresa.

El interés en corto en Corvus Pharma Corp (XNAS:CRVS) disminuyó durante el último período de informe, cayendo de 280,30 millones a 275,20 millones. Esto hizo que el 1,17 % de las acciones disponibles públicamente de la empresa se pusieran en corto.

Basado en el volumen promedio reciente de 545.03K acciones negociadas por día, tomaría 17.6 día(s) para que los poseedores de este interés corto cierren sus posiciones sin impulsar bruscamente el precio de las acciones.

Interés en corto
9.59M
Interés en corto %
16.3%
Días para cubrir
17.6
Get Alert
CRVS
Corvus Pharmaceuticals, Inc. C
08/29/2025
09/10/2025
16.29%
58,892,804
9,593,924
545,025
17.6
CRVS
Corvus Pharmaceuticals, Inc. C
08/15/2025
08/26/2025
15.78%
58,892,804
9,294,023
494,223
18.81
CRVS
Corvus Pharmaceuticals, Inc. C
07/31/2025
08/11/2025
14.30%
61,493,401
8,792,759
444,258
19.79
CRVS
Corvus Pharmaceuticals, Inc. C
07/15/2025
07/24/2025
14.61%
61,493,401
8,984,611
566,620
15.86
CRVS
Corvus Pharmaceuticals, Inc. C
06/30/2025
07/10/2025
14.48%
61,493,401
8,904,387
1,531,874
5.81
CRVS
Corvus Pharmaceuticals, Inc. C
06/13/2025
06/25/2025
12.91%
61,493,401
7,939,714
899,988
8.82
CRVS
Corvus Pharmaceuticals, Inc. C
05/30/2025
06/10/2025
11.51%
61,493,401
7,080,956
658,871
10.75
CRVS
Corvus Pharmaceuticals, Inc. C
05/15/2025
05/27/2025
11.76%
61,493,401
7,231,927
2,016,541
3.59
CRVS
Corvus Pharmaceuticals, Inc. C
04/30/2025
05/09/2025
10.99%
52,548,226
5,774,289
968,288
5.96
CRVS
Corvus Pharmaceuticals, Inc. C
04/15/2025
04/25/2025
9.54%
56,000,190
5,340,977
825,776
6.47
CRVS
Corvus Pharmaceuticals, Inc. C
03/31/2025
04/09/2025
8.78%
56,000,190
4,916,177
802,393
6.13
CRVS
Corvus Pharmaceuticals, Inc. C
03/14/2025
03/25/2025
10.34%
52,121,645
5,391,839
568,293
9.49
CRVS
Corvus Pharmaceuticals, Inc. C
02/28/2025
03/11/2025
10.26%
52,121,645
5,348,002
735,089
7.28
CRVS
Corvus Pharmaceuticals, Inc. C
02/14/2025
02/26/2025
11.00%
52,121,645
5,732,606
376,784
15.21
CRVS
Corvus Pharmaceuticals, Inc. C
01/31/2025
02/11/2025
11.72%
52,121,645
6,108,482
442,699
13.8
CRVS
Corvus Pharmaceuticals, Inc. C
01/15/2025
01/27/2025
10.56%
52,121,645
5,501,782
649,002
8.48
CRVS
Corvus Pharmaceuticals, Inc. C
12/31/2024
01/10/2025
10.42%
52,121,645
5,429,471
2,441,320
2.22
CRVS
Corvus Pharmaceuticals, Inc. C
12/13/2024
12/24/2024
8.26%
52,121,645
4,305,523
796,874
5.4
CRVS
Corvus Pharmaceuticals, Inc. C
11/29/2024
12/10/2024
6.74%
52,121,645
3,514,354
640,162
5.49
CRVS
Corvus Pharmaceuticals, Inc. C
11/15/2024
11/26/2024
6.33%
52,121,645
3,300,809
1,138,921
2.9
CRVS
Corvus Pharmaceuticals, Inc. C
10/31/2024
11/11/2024
5.80%
50,415,675
2,925,030
1,055,217
2.77
CRVS
Corvus Pharmaceuticals, Inc. C
10/15/2024
10/24/2024
4.85%
50,415,675
2,444,921
488,043
5.01
CRVS
Corvus Pharmaceuticals, Inc. C
09/30/2024
10/09/2024
4.26%
50,415,675
2,149,980
530,601
4.05
CRVS
Corvus Pharmaceuticals, Inc. C
09/13/2024
09/24/2024
3.25%
50,415,675
1,639,326
457,501
3.58
CRVS
Corvus Pharmaceuticals, Inc. C
08/30/2024
09/11/2024
2.84%
50,415,675
1,434,294
366,624
3.91
CRVS
Corvus Pharmaceuticals, Inc. C
08/15/2024
08/26/2024
2.71%
50,415,675
1,366,297
535,763
2.55
CRVS
Corvus Pharmaceuticals, Inc. C
07/31/2024
08/09/2024
2.28%
50,415,675
1,147,839
190,117
6.04
CRVS
Corvus Pharmaceuticals, Inc. C
07/15/2024
07/24/2024
2.49%
50,415,675
1,254,494
118,969
10.54
CRVS
Corvus Pharmaceuticals, Inc. C
06/28/2024
07/10/2024
2.84%
50,415,675
1,430,669
218,997
6.53
CRVS
Corvus Pharmaceuticals, Inc. C
06/14/2024
06/26/2024
2.98%
50,415,675
1,504,810
136,281
11.04
CRVS
Corvus Pharmaceuticals, Inc. C
05/31/2024
06/11/2024
3.01%
50,415,675
1,518,863
185,437
8.19
CRVS
Corvus Pharmaceuticals, Inc. C
05/15/2024
05/24/2024
2.55%
50,415,675
1,286,773
515,162
2.5
CRVS
Corvus Pharmaceuticals, Inc. C
04/30/2024
05/09/2024
2.69%
50,415,675
1,356,353
102,771
13.2
CRVS
Corvus Pharmaceuticals, Inc. C
04/15/2024
04/24/2024
3.70%
36,902,976
1,365,312
181,575
7.52
CRVS
Corvus Pharmaceuticals, Inc. C
03/28/2024
04/09/2024
3.79%
36,912,976
1,397,624
252,928
5.53
CRVS
Corvus Pharmaceuticals, Inc. C
03/15/2024
03/26/2024
4.05%
36,912,976
1,493,650
223,547
6.68
CRVS
Corvus Pharmaceuticals, Inc. C
02/29/2024
03/11/2024
3.45%
36,912,976
1,272,864
192,521
6.61
CRVS
Corvus Pharmaceuticals, Inc. C
02/15/2024
02/27/2024
3.45%
36,912,976
1,273,651
247,052
5.16
CRVS
Corvus Pharmaceuticals, Inc. C
01/31/2024
02/09/2024
3.73%
36,912,976
1,378,106
123,892
11.12
CRVS
Corvus Pharmaceuticals, Inc. C
01/12/2024
01/24/2024
3.79%
36,912,976
1,398,986
283,149
4.94
CRVS
Corvus Pharmaceuticals, Inc. C
12/29/2023
01/10/2024
3.61%
36,912,976
1,331,893
190,490
6.99
CRVS
Corvus Pharmaceuticals, Inc. C
12/15/2023
12/27/2023
3.53%
36,912,976
1,303,196
264,267
4.93
CRVS
Corvus Pharmaceuticals, Inc. C
11/30/2023
12/11/2023
4.26%
36,912,976
1,571,657
129,121
12.17
CRVS
Corvus Pharmaceuticals, Inc. C
11/15/2023
11/27/2023
4.85%
36,912,976
1,792,120
372,417
4.81
CRVS
Corvus Pharmaceuticals, Inc. C
10/31/2023
11/09/2023
4.64%
36,912,976
1,713,418
143,849
11.91
CRVS
Corvus Pharmaceuticals, Inc. C
10/13/2023
10/24/2023
4.81%
36,840,256
1,771,929
107,079
16.55
CRVS
Corvus Pharmaceuticals, Inc. C
09/29/2023
10/10/2023
4.81%
36,840,256
1,771,810
176,887
10.02
CRVS
Corvus Pharmaceuticals, Inc. C
09/15/2023
09/26/2023
4.95%
36,840,256
1,821,990
557,528
3.27

La gente también mira